ecteinascidin 743 has been researched along with Chordoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Constantinidou, A; Jones, RL; Loggers, E; Pollack, S; Rodler, E | 1 |
Choy, E; Duan, Z; Hornicek, FJ; Iafrate, J; Mankin, H; Nielsen, GP; Rosenberg, A; Schwab, JH; Wood, KB; Xavier, RJ; Yang, C | 1 |
1 review(s) available for ecteinascidin 743 and Chordoma
Article | Year |
---|---|
The evolution of systemic therapy in sarcoma.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chordoma; Deoxycytidine; Dermatofibrosarcoma; Dioxoles; Docetaxel; Drug Resistance, Neoplasm; Gemcitabine; Hemangiosarcoma; Humans; Osteosarcoma; Proteasome Inhibitors; Receptor, IGF Type 1; Sarcoma; Soft Tissue Neoplasms; Taxoids; Tetrahydroisoquinolines; TOR Serine-Threonine Kinases; Trabectedin | 2013 |
1 other study(ies) available for ecteinascidin 743 and Chordoma
Article | Year |
---|---|
Characterization and analysis of human chordoma cell lines.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Blotting, Western; Cell Culture Techniques; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Chordoma; Cisplatin; Collagen; Dioxoles; Doxorubicin; Drug Screening Assays, Antitumor; Fluorescent Antibody Technique; Glucose; Humans; Keratins; Tetrahydroisoquinolines; Trabectedin; Vimentin | 2010 |